Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL
This study has been completed.
Study NCT00236080   Information provided by Cephalon
First Received: October 7, 2005   Last Updated: July 3, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Shift Work Sleep Disorder
Additional conditions recognized in this trial
Disease
Sleep Disorders
Sleep Disorders, Circadian Rhythm
More general conditions related to this trial
Chronobiology Disorders
Disorders of Environmental Origin
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurologic Manifestations
Occupational Diseases
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
PROVIGIL
Additional drug interventions recognized in this trial
Modafinil
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Cephalon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services